Showing results (311-320 of 1,400) with videos related to
Sort By:
Pageof 140
Pharmacology Research & Perspectives|July 1, 2026
Development and Validation of an XGBoost-SHAP Model for Predicting Adverse Outcomes in Elderly Cardiovascular Patients With Polypharmacy: A Retrospective Cohort StudyKun Wang, Dandan CaoPharmacology Research & Perspectives|July 1, 2026
Deciphering the Functional Mechanisms of eIF3f in Tumors and Exploring Targeted TherapiesYujinpeng Hao, Jun Shao, Naqi Lian, et al.Pharmacology Research & Perspectives|June 19, 2026
Student and Graduate Perceptions of Their Development of the Core Attitudes From the British Pharmacological Society's Undergraduate Pharmacology CurriculumSophie G Reed, Aidan Seeley, Nicola Williams, et al.Pharmacology Research & Perspectives|July 7, 2026
Could NAPQI Contribute to Paracetamol Analgesia? Redox Modulation of Kv7 Ion ChannelsSara M-Alicante, Janire Urrutia, Arantza Muguruza-Montero, et al.Pharmacology Research & Perspectives|August 1, 2026
3D Liver Fibrosis Models in Lab: A Novel Modality for Drug ScreeningHani Keshavarz Alikhani, Fatemeh Majidi, Mahsa Ghasemzad, et al.Pharmacology Research & Perspectives|September 4, 2026
Securidaca inappendiculata Extract Mitigates Joint Damage in Collagen-Induced Arthritis Rats Through Modulation of the SIRT1/HIF-1α/Glycolysis PathwayYuyan Zhou, Yuyun Zhou, Ruoxuan Xiang, et al.Pharmacology Research & Perspectives|June 6, 2019
Long-term cardiovascular effects of vandetanib and pazopanib in normotensive ratsSamantha L Cooper, Joanne J Carter, Julie March, et al.Pharmacology Research & Perspectives|May 9, 2019
Target validation: Weak selectivity of LY341495 for mGluR2 over mGluR4 makes glutamate a less selective agonistTyler W McCullock, Paul J KammermeierPharmacology Research & Perspectives|October 17, 2018
Patterns of adverse drug reaction signals in NAFDAC pharmacovigilance activities from January to June 2015: safety of drug use in NigeriaOlufunsho Awodele, Rebecca Aliu, Ibrahim Ali, et al.Pharmacology Research & Perspectives|July 20, 2016
Benzolamide improves oxygenation and reduces acute mountain sickness during a high-altitude trek and has fewer side effects than acetazolamide at sea levelDavid J Collier, Chris B Wolff, Anne-Marie Hedges, et al.Pageof 140